Regioselective synthesis of 7-O-esters of the flavonolignan silibinin and SARs lead to compounds with overadditive neuroprotective effects
- 1 February 2018
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 146, 93-107
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Bioenergetics failure in neurodegenerative diseases: back to the futureExpert Opinion on Therapeutic Targets, 2012
- Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical LiteratureCold Spring Harbor Perspectives in Medicine, 2011
- Preparation of C-23 esterified silybin derivatives and evaluation of their lipid peroxidation inhibitory and DNA protective propertiesBioorganic & Medicinal Chemistry, 2009
- Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cellsInternational Journal of Cancer, 2008
- Mechanism of the Antioxidant Action of Silybin and 2,3-Dehydrosilybin Flavonolignans: A Joint Experimental and Theoretical StudyThe Journal of Physical Chemistry A, 2008
- Esterase Inhibition by Grapefruit Juice Flavonoids Leading to a New Drug InteractionDrug Metabolism and Disposition, 2007
- Effects of silymarin flavonolignans and synthetic silybin derivatives on estrogen and aryl hydrocarbon receptor activationToxicology, 2005
- Ferulic acid destabilizes preformed β-amyloid fibrils in vitroBiochemical and Biophysical Research Communications, 2005
- Induction of PC12 cell differentiation by flavonoids is dependent upon extracellular signal‐regulated kinase activationJournal of Neurochemistry, 2004
- Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stressNeuron, 1989